Richard A. Heyman
vc
About
Richard A. Heyman, PhD, is a biotech entrepreneur and scientist focused on oncology and drug discovery. He is chairman and co-founder of ORIC Pharmaceuticals, serves as chair or director at several biotech companies including Enliven Therapeutics, and holds investing roles at ARCH Venture Partners and Nextech Invest. He is also a senior ecosystem figure through the Salk Institute, UC San Diego Moores Cancer Center, AACR Foundation, and other nonprofit and advisory posts.
Areas of interest
biotechoncologyprecision oncologydrug discoverycancer resistancelife sciencestranslational medicinescientific researchphilanthropy